Fig. 5.
![Fig. 5. EFS according to BCL-2 expression levels in primary leukemic cells in immunophenotypically distinct patient subsets. The cumulative proportions of T-lineage ALL (shown in [A]) and B-lineage ALL (shown in [B]) patients surviving event-free are shown according to levels of BCL-2 expression on leukemic cells. Patients were divided into two groups: BCL-2 level ≥ median and BCL-2 level < median. BCL-2 level showed no prognostic effect on EFS in either subset.](https://ash.silverchair-cdn.com/ash/content_public/journal/blood/89/10/10.1182_blood.v89.10.3769/3/bl_0038f5.jpeg?Expires=1735552106&Signature=V1NUyztQiiQj5DKkeHc7EtynBeXeFRkUYFa3QuyCabAON8aIJn3p9GtapvrHSZsUlzpvr5bWhlz2Ou4aNCu8U3SF31OjIO2cWPhYMDGfLgnbb~1xRi5fuVGvuFsVP9PD2pb61v0J6aUO8isQ32d--6hvZ~M8t1IqMYO~2favAAyDbep7cMl4yqWprbFoADo-e97~5cFN3r3qliqE646I2OeQVT2nzYRELWmOXbDZFLmw6~vws-1O3KtpcFKEp~BooVUtS9dNz6asXcXP8mVaQaRcDv0i5ZaDAS8IOtuf2ptLCM4fvWylVPKKayHw4sse1u2peBz2ozJS~kXjXVczSw__&Key-Pair-Id=APKAIE5G5CRDK6RD3PGA)
EFS according to BCL-2 expression levels in primary leukemic cells in immunophenotypically distinct patient subsets. The cumulative proportions of T-lineage ALL (shown in [A]) and B-lineage ALL (shown in [B]) patients surviving event-free are shown according to levels of BCL-2 expression on leukemic cells. Patients were divided into two groups: BCL-2 level ≥ median and BCL-2 level < median. BCL-2 level showed no prognostic effect on EFS in either subset.
